Across TCGA pan-cancer cohorts, RPS7P13 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RPS7P13’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where RPS7P13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS7P13 is over-expressed in tumor.
STAD are the cancer types where RPS7P13 tumor–normal differential expression is most reproducible.